Skip to main content
SpringerLink
Log in

Opportunities and Challenges of Developing Peptide Drugs in the Pharmaceutical Industry

  • Conference paper
Peptides for Youth

Part of the book series: Advances in Experimental Medicine and Biology ((volume 611))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. D&MD publications. Peptides 2006. New Application in Discovery, Manufacturing, and Therapeutics. Sehgal, A., Author. One Research Drive, suite 400A. Wesborough, MA 01581.

    Google Scholar 

  2. Giuliano, F., J. Androl 25, 683–691 (2004).

    Google Scholar 

  3. MacNeil D. J. et al., Eur. J. Pharmacology, 450, 93–101 (2002).

    Article  CAS  Google Scholar 

  4. Danho, W. et al., in Peptides: The Wave of the Future. M. Lebel and R. Houghten (Editors) American Peptide Society, 701–703 (2001).

    Google Scholar 

  5. US Patens 6,600.015 and 7,045,591.

    Google Scholar 

  6. Martin, W.J. et al., Eur. J. Pharmacology, 454, 71–79 (2002).

    Article  CAS  Google Scholar 

  7. Cefalu, G. et al., Presented at Western Pharmacology Socirty Conference (2005).

    Google Scholar 

Download references

Acknowledgments

The authors wish to thank Drs. Lee Babiss, Nader Fotouhi, Jefferson Tilley, Rebecca Taub, Louis Renzetti, Michael Brunda, Waseem Malick, and Lisa Chao from Roche (Nutley) and Drs. Anthony Ford and Sally Meadows from Roche (Palo Alto) for stimulating discussions, their support and encouragement during the course of this research.

Author information

Authors and Affiliations

  1. Department of Pharmacology, University of Sherbrooke Medical School, Sherbrooke, QC, J1H 5N4, Canada

    Joseph Cefalu, Gretchen Cefalu & Philip Nunn

  2. Roche Research Center, Hoffmann-La Roche Inc. Nutley, New Jersey, 07110, USA

    Waleed Danho, Joseph Swistok, Wajiha Khan, Xin-Jie Chu, Adrian Cheung, David Fry, Hongmao Sun, Grazyna Kurylko & Leonid Rumennik

Authors
  1. Waleed Danho
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Joseph Swistok
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Wajiha Khan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Xin-Jie Chu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Adrian Cheung
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. David Fry
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Hongmao Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Grazyna Kurylko
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Leonid Rumennik
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Joseph Cefalu
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Gretchen Cefalu
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Philip Nunn
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Chemistry & Biochemistry, New Mexico State University, 1175 N. Horseshoe Drive, Las Cruces, NM, 88003-8001, USA

    Susan Del Valle

  2. Department of Pharmacology, University of Sherbrooke Medical School, Sherbrooke, QC, J1H 5N4, Canada

    Emanuel Escher

  3. Département de Chimie, Université de Montréal, C.P. 6128, Succursale Centre Ville, Montréal, QC, H3C 3J7, Canada

    William D. Lubell

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer Science+Business Media, LLC

About this paper

Cite this paper

Danho, W. et al. (2009). Opportunities and Challenges of Developing Peptide Drugs in the Pharmaceutical Industry. In: Valle, S.D., Escher, E., Lubell, W.D. (eds) Peptides for Youth. Advances in Experimental Medicine and Biology, vol 611. Springer, New York, NY. https://doi.org/10.1007/978-0-387-73657-0_201

Download citation

Publish with us

Policies and ethics

Search

Navigation